News Headlines
-
Lab Oversupply Is Pushing Leasing, Rent and Relocation Down
7/1/2025
The landscape of the U.S. pharmaceutical lab market is changing, according to JLL’s U.S. Life Sciences Property Report. In addition to the effort to bring pharma manufacturing back to the U.S. ahead of looming tariffs, an oversupply of space and lower tenant demand in large biopharma markets is dropping leasing rates, rent costs and lease duration, among other changes.
-
Soligenix Announces Synthetic Hypericin Successfully Manufactured At Sterling Pharma Solutions
7/1/2025
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has successfully completed the transfer of the manufacturing process for its synthetic hypericin active ingredient under its partnership agreement with Sterling Pharma Solutions (Sterling).
-
HanchorBio And Henlius Sign Major Licensing Deal For HCB101 To Expand Global Immuno-Oncology Reach
7/1/2025
HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune diseases, today announces the signing of a major out-licensing agreement with Shanghai Henlius Biotech, Inc. (hereafter "Henlius").
-
WuXi XDC Announces The Mechanical Completion Of Its Singapore Site, Accelerating The Global Expansion Of Bioconjugates Manufacturing
7/1/2025
On June 30, WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced that the mechanical completion of its manufacturing site at Tuas Biomedical Park in Singapore has been successfully achieved.
-
First Cohort Graduates Biomanufacturing Certification Program At Spokane Colleges
6/30/2025
Ten students graduated from the inaugural Essentials in Biomanufacturing Certification program on June 26, 2025, at Spokane Colleges. Jubilant HollisterStier (JHS), a contract pharmaceutical manufacturing company, partnered with Spokane Colleges to develop this specialized training program to jumpstart careers in the growing life sciences industry.
-
USpharma Ltd. Secures Growth Capital Investment By 1315 Capital
6/30/2025
USpharma Ltd., a pharmaceutical development and manufacturing company commercializing several novel delivery platforms, today announced a significant growth equity investment by 1315 Capital, a Philadelphia-based healthcare growth equity firm.
-
ten23 Health Joins The 'Alliance For RTU' - An Association To Advance Technical Exchange For Ready-To-Use (RTU) Containers In Sterile Manufacturing
6/30/2025
ten23 health, the human-centric and sustainable strategic CDTMO partner of choice for the pharmaceutical industry and biotech start-ups, has joined the „Alliance for RTU“, an association to advance technical exchange for readyto-use (RTU) containers in sterile manufacturing.
-
Particle Dynamics Acquires EuroAPI UK; A Commercial Spray Drying Facility In Haverhill, UK
6/30/2025
Particle Dynamics, a global leader in particle processing and delivery technologies, has acquired EUROAPI UK Ltd., an operator of a commercial spray drying facility in Haverhill, UK.
-
Axplora Announces Further €35M Expansion At Farmabios To Double Footprint And Fuel Long-Term Growth
6/30/2025
Axplora is proud to unveil a transformative €35M expansion at its Farmabios site in Gropello Cairoli, Italy, reinforcing the company’s longstanding commitment to serving the evolving needs of its customers through strategic investment and innovation.
-
EUROAPI Sells Haverhill Site To Particle Dynamics As Part Of Its FOCUS-27 Transformation Plan
6/30/2025
EUROAPI today announced the signing of a share purchase agreement (SPA) for the sale of 100% of EUROAPI UK Ltd, the subsidiary operating its Haverhill manufacturing site, with a simultaneous closing to Particle Dynamics - a global leader in particle processing, delivery technologies, and finished dose manufacturing for the nutraceutical, consumer health, and pharmaceutical sectors.